Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  New England Journal of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 10379020
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. Newborn Lung Project.

  1998cited by this paper
• Vitamin A to prevent bronchopulmonary dysplasia in very-low-birth-weight infants: has the dose been too low? The NICHD Neonatal Research Network.

  1997cited by this paper
• Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats.

  1996cited by this paper
• Use of the intramuscular relative-dose-response test to predict bronchopulmonary dysplasia in premature infants.

  1996cited by this paper
• Impact of neonatal vitamin A supplementation on infant morbidity and mortality.

  1996cited by this paper
• Sequential evaluation of plasma retinol-binding protein response to vitamin A administration in very-low-birth-weight neonates.

  1995cited by this paper
• Intramuscular versus enteral vitamin A supplementation in very low birth weight neonates.

  1994cited by this paper
• Safety of one 52-mumol (50,000 IU) oral dose of vitamin A administered to neonates.

  1994cited by this paper
• Postnatal changes in serum retinol status in very low birth weight infants.

  1994cited by this paper
• Epidemiology of acute and chronic lung injury.

  1993cited by this paper
• Vitamin A supplementation and child mortality. A meta-analysis.

  1993cited by this paper
• Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia.

  1992cited by this paper
• Tolerance of young infants to a single, large dose of vitamin A: a randomized community trial in Nepal.

  1992cited by this paper
• Concentrations of selected carotenoids and vitamin A in human liver, kidney and lung tissue.

  1991cited by this paper
• The Effect of Glucocorticosteroids on Serum, Liver, and Lung Vitamin A and Retinyl Ester Concentrations

  1991cited by this paper
• Plasma retinol-binding protein response to vitamin A administration in infants susceptible to bronchopulmonary dysplasia.

  1990cited by this paper
• Effect of postnatal steroid administration on serum vitamin A concentrations in newborn infants with respiratory compromise.

  1989cited by this paper
• Safety of vitamin A.

  1989cited by this paper
• Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period.

  1988cited by this paper
• Persistently low blood retinol levels during and after parenteral feeding of very low birth weight infants: examination of losses into intravenous administration sets and a method of prevention by addition to a lipid emulsion.

  1987cited by this paper
• Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia.

  1987cited by this paper
• Liver Vitamin A Reserves of Very Low Birth Weight Neonates

  1985cited by this paper
• Vitamin A Status of Neonates with Bronchopulmonary Dysplasia

  1985cited by this paper
• Assessment of marginal vitamin A deficiency in Brazilian children using the relative dose response procedure.

  1984cited by this paper
• Serum levels of vitamin A and carotenoids as reflectors of nutritional status.

  1984cited by this paper
• Plasma vitamin A and retinol-binding protein in premature and term neonates.

  1981cited by this paper
• A simplified score for assessment of fetal maturation of newly born infants.

  1979cited by this paper

• Evidence-based early-post natal approaches to limiting pulmonary disease in extremely low birth weight infants.

  2026cites this paper
• The Destructive Cycle in Bronchopulmonary Dysplasia: The Rationale for Systems Pharmacology Therapeutics

  2025cites this paper
• Influenza virus-induced type I interferons disrupt alveolar epithelial repair and tight junction integrity in the developing lung

  2025cites this paper
• Vitamin A in donor human milk: An experimental study.

  2025cites this paper
• Narrative review of micronutrients and fatty acids in bronchopulmonary dysplasia

  2025cites this paper
• Preventing Bronchopulmonary Dysplasia Through Nutrition in Preterm Infants: A Systematic Review of the Literature.

  2025cites this paper
• Two-year outcomes after early postnatal high-dose fat-soluble enteral vitamin A supplementation in extremely low birth weight infants: follow-up of the NeoVitaA randomized controlled trial

  2025cites this paper
• Is enteral vitamin A supplementation the right approach for preventing bronchopulmonary dysplasia in preterm infants?

  2025cites this paper
• Age Matters: Key Contributors to Interferon Toxicity in Infants During Influenza Virus Infection

  2025cites this paper
• The effect of vitamin supplementation on neurodevelopmental and clinical outcomes in very low birth weight and very preterm infants: A systematic review and meta-analysis

  2025cites this paper
• Current and Emerging Therapies for Prevention and Treatment of Bronchopulmonary Dysplasia in Preterm Infants

  2025cites this paper
• A Rapid Fluorescence Method for In Vivo Quantitation of Lung Deposition of a Nebulized Drug: Multiple Uses for Advancing Aerosolized Drug Development and Specific Insight Regarding Aerosolized Vitamin A for Preventing Bronchopulmonary Dysplasia

  2025cites this paper
• Take a deep breath: the important role of vitamin A in neonatal lung development and visiting the potential of aerosolized delivery for bronchopulmonary dysplasia prevention

  2025cites this paper
• Strategies for the prevention of bronchopulmonary dysplasia

  2024cites this paper
• Endoplasmic Reticulum Stress in Bronchopulmonary Dysplasia: Contributor or Consequence?

  2024cites this paper
• Association of Fetal Lung Development Disorders with Adult Diseases: A Comprehensive Review

  2024cites this paper
• Temporal Dynamics of Oxidative Stress and Inflammation in Bronchopulmonary Dysplasia

  2024cites this paper
• Association of Growth During Infancy With Neurodevelopment and Obesity in Children Born Very Preterm: The Environmental influences on Child Health Outcomes Cohort.

  2024cites this paper
• Prevalence, Prevention and Management of Bronchopulmonary Dysplasia

  2024cites this paper
• Effects of primary or secondary prevention with vitamin A supplementation on clinically important outcomes: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis

  2024cites this paper
• Nutritional Needs of the Infant with Bronchopulmonary Dysplasia.

  2024cites this paper
• Role of Myeloperoxidase, Oxidative Stress, and Inflammation in Bronchopulmonary Dysplasia

  2024cites this paper
• Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.

  2024cites this paper
• Vitamin A and bronchopulmonary dysplasia: the next steps.

  2024cites this paper
• Interventions to Reduce Severe Brain Injury Risk in Preterm Neonates

  2023cites this paper
• Oxygen and mechanical stretch in the developing lung: risk factors for neonatal and pediatric lung disease

  2023cites this paper
• Developing a Respiratory Quality Improvement Program to Prevent and Treat Bronchopulmonary Dysplasia in the Neonatal Intensive Care Unit.

  2023cites this paper
• The beneficial effect of prophylactic hydrocortisone treatment in extremely preterm infants improves upon adjustment of the baseline characteristics

  2023cites this paper
• Pharmacotherapy of BPD: Current status & future perspectives.

  2023cites this paper
• Prevention of Chronic Morbidities in Extremely Premature Newborns with LISA-nCPAP Respiratory Therapy and Adjuvant Perinatal Strategies

  2023cites this paper
• Contributions of the NICHD neonatal research network to the diagnosis, prevention, and treatment of bronchopulmonary dysplasia.

  2022cites this paper
• Contributions of the NICHD neonatal research network's generic database to documenting and advancing the outcomes of extremely preterm infants.

  2022cites this paper
• Moving Bronchopulmonary Dysplasia Research from the Bedside to the Bench.

  2022cites this paper
• When inflammation meets lung development—an update on the pathogenesis of bronchopulmonary dysplasia

  2022cites this paper
• Oral vitamin A supplementation in preterm infants to improve health outcomes: A systematic review and meta-analysis

  2022cites this paper
• The critical importance of follow-up to school age: Contributions of the NICHD Neonatal Research Network.

  2022cites this paper
• Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?

  2022cites this paper
• Pulmonary and Neurologic Effects of Mesenchymal Stromal Cell Extracellular Vesicles in a Multifactorial Lung Injury Model.

  2022cites this paper
• Growth During Infancy after Extremely Preterm Birth: Associations with Later Neurodevelopmental and Health Outcomes.

  2022cites this paper
• Early Vitamin A Supplementation for Prevention of Short-Term Morbidity and Mortality in Very-Low-Birth-Weight Infants: A Systematic Review and Meta-Analysis

  2022cites this paper
• Antioxidants: Role the in prevention and treatment of bronchopulmonary dysplasia.

  2022cites this paper
• A Narrative Review of Vitamin A Supplementation in Preterm and Term Infants

  2022cites this paper
• Commentary on “compatibility of rapid enteral feeding advances and noninvasive ventilation in preterm infants—an observational study”

  2022cites this paper
• Nutrition Support Practices for Infants Born <750 Grams or <25 Weeks Gestation: A Call for More Research

  2022cites this paper
• Nutritional Supplements to Improve Outcomes in Preterm Neonates.

  2022cites this paper
• A systematic review and meta-analysis

  2021cites this paper
• Retinoic acid regulates erythropoietin production cooperatively with hypoxia-inducible factors in human iPSC-derived erythropoietin-producing cells

  2021cites this paper
• Translational Research in Retinopathy of Prematurity: From Bedside to Bench and Back Again

  2021cites this paper
• Hydrogen Sulfide—Clues from Evolution and Implication for Neonatal Respiratory Diseases

  2021cites this paper
• Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants

  2021cites this paper
• Vitamin A supplementation in very-preterm or very-low-birth-weight infants to prevent morbidity and mortality: a systematic review and meta-analysis of randomized trials.

  2021cites this paper
• Diagnosis and management of bronchopulmonary dysplasia

  2021cites this paper
• Effects of neonatal nutrition interventions on neonatal mortality and child health and development outcomes: A systematic review

  2021cites this paper
• Vitamin A supplementation for very preterm infants back on the menu-for some or all?

  2021cites this paper
• Systematic review of the healthcare cost of bronchopulmonary dysplasia

  2021cites this paper
• The Role of Nutrition in the Prevention and Management of Bronchopulmonary Dysplasia: A Literature Review and Clinical Approach

  2021cites this paper
• Intrauterine Hypoxia and Epigenetic Programming in Lung Development and Disease

  2021cites this paper
• Surfactant protein D and bronchopulmonary dysplasia: a new way to approach an old problem

  2021cites this paper
• Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants?: Reanalysis of the NICHD Neonatal Research Network Randomized Trial.

  2021cites this paper
• Enteral Vitamin A for Reducing Severity of Bronchopulmonary Dysplasia: A Randomized Trial

  2021cites this paper
• Neurodevelopmental outcomes of infants with bronchopulmonary dysplasia

  2021cites this paper
• Rates of Bronchopulmonary Dysplasia Following Implementation of a Novel Prevention Bundle

  2021cites this paper
• The effects of early vitamin A supplementation on the prevention and treatment of bronchopulmonary dysplasia in premature infants: a systematic review and meta-analysis

  2021cites this paper
• Inhaled vitamin A is more effective than intramuscular dosing in mitigating hyperoxia-induced lung injury in a neonatal rat model of bronchopulmonary dysplasia.

  2020cites this paper
• Recent advances in understanding and management of bronchopulmonary dysplasia

  2020cites this paper
• [Expert consensus on nutritional management of preterm infants with bronchopulmonary dysplasia].

  2020cites this paper
• Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis

  2020cites this paper
• Systematic Review and Meta-Analysis of the Relative Dose-Response Tests to Assess Vitamin A Status.

  2020cites this paper
• Lung functional development and asthma trajectories

  2020cites this paper
• Families’ perspectives on monitoring infants’ health and development after discharge from NICUs

  2020cites this paper
• Nutrients and Microbiota in Lung Diseases of Prematurity: The Placenta-Gut-Lung Triangle

  2020cites this paper
• Oxygen and pulmonary vasodilation: The role of oxidative and nitrosative stress.

  2020cites this paper
• Pharmacotherapy for the Prevention of Bronchopulmonary Dysplasia: Can Anything Compete with Caffeine and Corticosteroids?

  2019cites this paper
• Oral vitamin A supplementation in very low birth weight neonates: a randomized controlled trial

  2019cites this paper
• Lung disease and pulmonary hypertension in the premature infant.

  2019cites this paper
• High amplitude bubble continuous positive airway pressure decreases lung injury in rats with ventilator-induced lung injury.

  2019cites this paper
• Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period.

  2019cites this paper
• Role of vitamin A supplementation in prevention of bronchopulmonary dysplasia in extremely low birth weight neonates: a systematic review of randomized trials

  2019cites this paper
• Prevention of Bronchopulmonary Dysplasia: A Summary of Evidence-Based Strategies.

  2019cites this paper
• Intramuscular Followed by Oral Vitamin A Supplementation in Neonates with Birth Weight from 750 to 1250 g: A Randomized Controlled Trial

  2019cites this paper
• Therapies that enhance pulmonary vascular NO-signaling in the neonate.

  2019cites this paper
• Bronchopulmonary Dysplasia: Executive Summary of a Workshop

  2018cites this paper
• [Research progress in drug therapy for bronchopulmonary dysplasia in preterm infants].

  2018cites this paper
• Recent Advances in Bronchopulmonary Dysplasia: Pathophysiology, Prevention, and Treatment

  2018cites this paper
• Bronchopulmonary dysplasia

  2018cites this paper
• Oxidative Stress and Neonatal Respiratory Extracorporeal Membrane Oxygenation

  2018cites this paper
• Reactive Oxygen Species, Biomarkers of Microvascular Maturation and Alveolarization, and Antioxidants in Oxidative Lung Injury.

  2018cites this paper
• Fat-soluble vitamins A and E and health disparities in a cohort of pregnant women at delivery

  2018cites this paper
• Immature megalin expression in the preterm neonatal kidney is associated with urinary loss of vitamin carrier proteins

  2018cites this paper
• ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Vitamins.

  2018cites this paper
• Vitamin A Supplementation by Endotracheal Application of a Nano-encapsulated Preparation Is Feasible in Ventilated Preterm Lambs

  2018cites this paper
• Nutrition and Lung Growth

  2018cites this paper
• Status of Retinoids and Carotenoids and Associations with Clinical Outcomes in Maternal-Infant Pairs in Nigeria

  2018cites this paper
• Nutrition Support Team Guide to Maternal Diet for the Human‐Milk‐Fed Infant

  2018cites this paper
• Vitamin A to prevent bronchopulmonary dysplasia in extremely low birth weight infants: a systematic review and meta-analysis

  2018cites this paper
• Efficacy of glucocorticoids, vitamin A and caffeine therapies for neonatal mortality in preterm infants: a network meta-analysis

  2017cites this paper
• Inhibition of pulmonary β-carotene 15, 15’-oxygenase expression by glucocorticoid involves PPARα

  2017cites this paper
• Up-date on the NeoVitaA Trial: Obstacles, challenges, perspectives, and local experiences

  2017cites this paper
• Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development

  2017cites this paper
• Prevention of bronchopulmonary dysplasia: current strategies.

  2017cites this paper